Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Arcus Biosciences Inc RCUS

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical... see more

Recent & Breaking News (NYSE:RCUS)

Gilead Exercises Options to Three Arcus Biosciences Clinical-Stage Programs and Adds Research Collaboration

Business Wire November 18, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire November 9, 2021

Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab

Business Wire November 8, 2021

Arcus Biosciences to Report Third Quarter 2021 Financial Results & Recent Corporate Highlights

Business Wire November 2, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire October 26, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire October 11, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire September 27, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire September 9, 2021

Arcus Biosciences to Participate at Upcoming Investor Conferences

Business Wire September 1, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire August 24, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire August 10, 2021

Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights

Business Wire August 5, 2021

Arcus Biosciences to Participate at the 2021 Wedbush PacGrow Virtual Healthcare Conference

Business Wire August 4, 2021

Arcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights

Business Wire July 29, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire July 26, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire July 12, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire June 24, 2021

Anti-TIGIT Domvanalimab-Based Combinations Showed Encouraging Clinical Activity in People with Metastatic, PDL1-High Non-Small Cell Lung Cancer at First Interim Analysis of Arcus Biosciences' Randomized Phase 2 ARC-7 Study

Business Wire June 23, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire June 9, 2021

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire May 25, 2021